NCT06250036
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06250036
Title Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer (ZODIAC)
Acronym ZODIAC
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Royal Marsden NHS Foundation Trust
Indications
Therapies
Age Groups: adult | senior
Covered Countries GBR

Facility Status City State Zip Country Details
Addenbrooke's Hospital RECRUITING Cambridge Cambridgeshire CB2 0QQ United Kingdom Details
Royal Devon University Healthcare Foundation Trust RECRUITING Exeter Devon EX2 5DW United Kingdom Details
Ninewells hospital and Medical School RECRUITING Dundee Dundee DD1 9SY United Kingdom Details
Kent & Canterbury Hospital RECRUITING Canterbury Kent CT1 3NG United Kingdom Details
Guy's and St Thomas' NHS Foundation Trust RECRUITING London London SE1 9RT United Kingdom Details
The Royal Marsden NHSFT RECRUITING London London SW3 6JJ United Kingdom Details
St James's University hospital RECRUITING Leeds Yorkshire LS9 7TF United Kingdom Details
St Bartholomew's Hospital RECRUITING London EC1A 7BE United Kingdom Details
University College London Hospital NHS Foundation Trust RECRUITING London N15 6UL United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field